Compare Godaddy Inc (GDDY) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs IDEXX Laboratories, Inc. — how do they compare? Godaddy Inc trades at $104.37 (market cap $13.07B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.1× Godaddy Inc's market cap, and Godaddy Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 64 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| GDDY | IDXX | |
|---|---|---|
Market Cap | $13.07B | $40.43B |
Volume | 1,831,274 | 692,164 |
Sector | Technology | Health |
52-Week High | $135.18 | $766.68 |
52-Week Low | $75.07 | $504.70 |
Typical Hold Time | 64 Days | 46 Days |
Enterprise Value | $15.75B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $103.19, up 6.15% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with $4.95B revenue, 17.83% net margin, and consistent earnings beats in recent quarters. However, the stock faces headwinds from multiple securities class action lawsuits alleging misrepresentation of domain contract terms during September 2025-February 2026 period, creating significant legal overhang despite positive operational performance.
While GoDaddy maintains strong profitability and analyst support (58% buy ratings), the legal challenges present substantial near-term risk. The stock trades above consensus price target of $96.20, suggesting limited upside potential. Investors must weigh robust financial performance against litigation uncertainties that could impact shareholder value through settlements or reputational damage.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
